Autism Clinical Trials in Atlanta, Georgia
7 recruitingAtlanta, Georgia
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
SchizophreniaAutism-Related Irritability
Karuna Therapeutics, Inc., a Bristol Myers Squibb company400 enrolled55 locationsNCT07424404
Recruiting
Not Applicable
Evaluating Georgia Part C Implementation Outcomes
AutismCommunication Disorder, Childhood
Emory University80 enrolled1 locationNCT07148258
Recruiting
Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement
AutismInfant Development
Emory University2,120 enrolled2 locationsNCT05916430
Recruiting
Phase 3
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
SchizophreniaAutism Spectrum DisorderBipolar Disorder
Intra-Cellular Therapies, Inc.500 enrolled50 locationsNCT06229210
Recruiting
Phase 3
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Intra-Cellular Therapies, Inc.174 enrolled39 locationsNCT06706674
Recruiting
Not Applicable
Early Diagnostic Response Model (EDRM)
AutismAutism Spectrum Disorder
Emory University300 enrolled1 locationNCT05419895
Recruiting
Phase 1
Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder
Autism Spectrum Disorder
Intra-Cellular Therapies, Inc.26 enrolled8 locationsNCT06557902